Melanie R. Baxter

Room 543-745 Bannatyne Avenue
Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

'Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-2021-right-to-reply'.

'Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-2021-right-to-reply'.

Journal: The Journal of antimicrobial chemotherapy

Published: March 31, 2026

Mechanisms of fosfomycin resistance observed in clinical isolates of Escherichia coli from Canada: CANWARD 2007-2022.

Mechanisms of fosfomycin resistance observed in clinical isolates of Escherichia coli from Canada: CANWARD 2007-2022.

Journal: JAC-antimicrobial resistance

Published: November 11, 2025

Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).

Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).

Journal: The Journal of antimicrobial chemotherapy

Published: August 28, 2025

Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 17 years of the CANWARD study (2007-23).

Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 17 years of the CANWARD study (2007-23).

Journal: The Journal of antimicrobial chemotherapy

Published: August 28, 2025

Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

Journal: The Journal of antimicrobial chemotherapy

Published: August 28, 2025

Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23).

Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23).

Journal: The Journal of antimicrobial chemotherapy

Published: August 28, 2025

Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23).

Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23).

Journal: The Journal of antimicrobial chemotherapy

Published: August 28, 2025

Distribution and antimicrobial susceptibility profile of pathogens recovered from the bloodstream of Canadian patients: results from the CANWARD study (2007-23).

Distribution and antimicrobial susceptibility profile of pathogens recovered from the bloodstream of Canadian patients: results from the CANWARD study (2007-23).

Journal: The Journal of antimicrobial chemotherapy

Published: August 28, 2025

Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23.

Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23.

Journal: The Journal of antimicrobial chemotherapy

Published: August 28, 2025

Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

Journal: The Journal of antimicrobial chemotherapy

Published: August 28, 2025

Enterococcus faecium harbouring vanA, optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance case.

Enterococcus faecium harbouring vanA, optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance case.

Journal: The Journal of antimicrobial chemotherapy

Published: July 30, 2025

In Vitro activity of ceftobiprole against 20,255 recent clinical bacterial isolates in Canada (CANWARD 2015-2023).

In Vitro activity of ceftobiprole against 20,255 recent clinical bacterial isolates in Canada (CANWARD 2015-2023).

Journal: Diagnostic microbiology and infectious disease

Published: March 07, 2025

Showing 1-12 of 81

Last Updated: 09/26/2026